CSF1 and neoplasm: In addition to regulating neutrophils, LY500307 reduced the recruitment of CSF-1 receptor-positive myeloid-derived suppressor cells (MDSC) to the tumor microenvironment while also increasing CD8+ cytotoxic T cells by decreasing the production of CSF-1 by tumor cells (Figure 4D) [113].